• PIN85 Burden of Methicillin-Resistant Staphylococcus Aureus Bacteremia on Hospitals in the United States- Results From a National Database

    Nov 1, 2012, 00:00

  • PR2 A Feasibility Study of Preference-Based Health-Related Quality of Life Measures on Patients With Irritable Bowel Syndrom in Taiwan

    Nov 1, 2012, 00:00

  • PCN22 Immunotherapy With Sipuleucel-T (APC8015) in Patients With Metastatic Castration-Refractory Prostate Cancer (mCRPC)- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PND5 A Mixed Treatment Comparison of Gabapentin Enacarbil, Pramipexole, Ropinirole and Rotigotine in Moderate-to-Severe Restless Legs Syndrome (RLS)

    Nov 1, 2012, 00:00

  • PDB20 Estimating the Direct Medical Costs Associated with Diabetes-Related Complications in Indonesia

    Nov 1, 2012, 00:00

  • PHP84 The Economic Health Value from Rx to OTC Switch in Greece

    Nov 1, 2012, 00:00

  • PIN24 Clinical and Economic Evaluation of an Adult Pneumococcal Vaccination Programme Aimed at the Spanish HIV Population

    Nov 1, 2012, 00:00

  • PRM168 An Integrated Formal Framework for Reimbursement, Research and Pricing Deliberations in Health Technology Assessment

    Nov 1, 2012, 00:00

  • PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

    Nov 1, 2012, 00:00

  • PSY9 Real-Life Cost-Analyses of Chronic Low-Back Pain Patients With Neuropathic Pain Components in Denmark

    Nov 1, 2012, 00:00

  • PHS35 The Distribution of Outpatient Physiotherapy Services in Hungary

    Nov 1, 2012, 00:00

  • PIH42 Effectiveness of a Protocol for Respiratory Syncytial Virus (RSV) Immunoprophylaxis in Pre-Term Infants Born at 34 Weeks Gestation Age

    Nov 1, 2012, 00:00

  • PSU4 Regional Variation in Angiogram Use for Patients Who Underwent Coronary Artery Bypass Graft Surgery

    Nov 1, 2012, 00:00

  • PHS56 Evaluation of Telemedicine Program (ITHACA)- Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and Adherence

    Nov 1, 2012, 00:00

  • PSY12 The Cost of Treating Chronic Myeloid Leukemia (CML) in Greece

    Nov 1, 2012, 00:00

  • PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over Time

    Nov 1, 2012, 00:00

  • PHP188 Funding the Unfundable- The Australian Approach for Specialty Pharmaceuticals

    Nov 1, 2012, 00:00

  • PIN33 Corsar-Study (Cost and Resource Utilisation Study in Antiretroviral Treated Patients)

    Nov 1, 2012, 00:00

  • PSY40 Health-Related Quality of Life and Annual Direct Medical Cost of Patients With Haemophilia B in Fran The EQOFIX Study

    Nov 1, 2012, 00:00

  • PDB25 HbA1C Targets for Patients With Type 2 Diabetes- Results of a Systematic Literature Review

    Nov 1, 2012, 00:00

  • PND68 Comparison of Hospitalizations Among Parkinson'S Patients Who Initiated Therapy With a Dopamine Agonist or Rasagiline- Evidence From the Medicare Supplemental Database

    Nov 1, 2012, 00:00

  • PCN118 Impact of Bone Metastases on Quality of Life in Patients With Castration-Resistant Prostate Cancer (CRPC) at High Risk for Developing Bone Metastases

    Nov 1, 2012, 00:00

  • PHP1 A Qualitative Exploration of Malaysian Cancer Patients' Perceptions Towards Cancer Screening

    Nov 1, 2012, 00:00

  • PIH38 Capturing Quality of Life in Conditions with Fluctuating Symptoms

    Nov 1, 2012, 00:00

  • NI1 Three Years of Nice Scientific Advi Comprehensive Analysis of Requests to the Programme

    Nov 1, 2012, 00:00

  • PIH20 Cost-Effectiveness of Supplemental N-3 in Total Parenteral Nutrition Therapy in the Italian, French, German and UK Context- A Discrete Event Simulation Model

    Nov 1, 2012, 00:00

  • PMS38 Cost-Effectiveness of Tapentadol for Severe Chronic Non-Cancer Pain in Belgium

    Nov 1, 2012, 00:00

  • PSU11 Medical Costs Comparison Between Internal Fixation and Arthoplasty in Patients With Hip Femoral Neck Fractures

    Nov 1, 2012, 00:00

  • PRM167 The Value of Choice in a Collectively Funded Health System- An Extended Analytical Approach to Examine the Conflict Between Decisions at Individual and Societal Level

    Nov 1, 2012, 00:00

  • PHP85 The Use of Biomarkers in Cancer Trials in Asia

    Nov 1, 2012, 00:00

  • PSU13 Survival and Cost Comparison of Balloon-Kyphoplasty and Vertebroplasty Using German Claims Data

    Nov 1, 2012, 00:00

  • PCN140 The Evaluation of Health Care Resource Utilization in Patients With Metastatic Castration Resistant Prostate Cancer- Results of a Multinational Observational Study

    Nov 1, 2012, 00:00

  • PCN145 Observational Macro Analysis on the Aggregated Cigarette Price Elasticity in Denmark 1978-2010

    Nov 1, 2012, 00:00

  • PIH5 Provider Payment and Cost of Treatment for Complicated Delivery Care- Evidence From Case Studies in Indonesia

    Nov 1, 2012, 00:00

  • PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation

    Nov 1, 2012, 00:00

  • PHP116 Orphan Drug Pricing and Access – Current Situation and Future Trends in EU

    Nov 1, 2012, 00:00

  • PND14 Budgetary Impact of the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain

    Nov 1, 2012, 00:00

  • DU3 Market Access Delays for CNS Drugs in Europe

    Nov 1, 2012, 00:00

  • PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With Duloxetine

    Nov 1, 2012, 00:00

  • PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in Kazakhstan

    Nov 1, 2012, 00:00

  • PHP3 Adherence to the Clinical Practice Guidelines in the Management of Chronic Ischemic Heart Failure in a District Hospital

    Nov 1, 2012, 00:00

  • PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective

    Nov 1, 2012, 00:00

  • PHS97 An Off-the-Shelf Catalogue of Quality Improvement Interventions to Implement in the Prevention of Pressure Ulcers for Hospital Settings

    Nov 1, 2012, 00:00

  • PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures

    Nov 1, 2012, 00:00

  • PCV16 Associations Between Patient Demographics, Pharmacotherapy Use, and Cost, Resource Utilization, and Quality-of-Life Burden in Adult Cardiac Arrhythmia Patients

    Nov 1, 2012, 00:00

  • PMD93 Practice Variation in Diagnostic Imaging Workup and Treatment Criteria Following a Recent TIA or Minor Ischemic Stroke- Consequences for Early Economic Evaluations

    Nov 1, 2012, 00:00

  • PMD30 Short Term Health-Economic Outcomes of Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes- A Cost Comparison Analysis

    Nov 1, 2012, 00:00

  • PMS24 A Systematic Review of Existing Utility Weight Estimates in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PHP84 Lung Cancer Treatment- A Paradigm Shift to Targeted Therapies in Clinical Trial Settings in Asia

    Nov 1, 2012, 00:00

  • PIN18 Antimicrobial Resistance (AMR) in Thailand- A Systematic Review

    Nov 1, 2012, 00:00

  • PDB30 The Prevalence and Burden of Comorbid Hypertension and Obesity among Patients With Type 2 Diabetes in Japan

    Nov 1, 2012, 00:00

  • PCN35 Survival Estimates of Six Major Advanced and Metastatic Solid Tumors in Europe- A Cancer Registry and Literature Review

    Nov 1, 2012, 00:00

  • PHP94 Determinants of Drug Therapy Problems among Medicaid Patients Receiving a Telephonic Medication Therapy Management Program

    Nov 1, 2012, 00:00

  • PIN75 Health-Related Quality of Life of Clostridium Difficile Infection- A Methodological Contribution to Direct Utility Elicitation by TTO

    Nov 1, 2012, 00:00

  • PMD41 Economic Evaluation of Continuous Subcutaneous Insulin Infusion for Children With Diabetes – a Pilot Study

    Nov 1, 2012, 00:00

  • PCV7 A Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients with Non-Valvular Atrial Fibrillation (NVAF)

    Nov 1, 2012, 00:00

  • PRM105 Predicting Subjective Antimuscarinic Effectiveness on Symptoms of Overactive Bladder Using the Eight-Item Overactive Bladder Awareness Tool (OAB-V8)

    Nov 1, 2012, 00:00

  • PHS43 Cost-Effectiveness Analysis of Therapeutic Drug Monitoring in Pediatric Patients Diagnosed With Structural-Metabolic Epilepsy

    Nov 1, 2012, 00:00

  • PGI7 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapies in Ulcerative Colitis (UC)- A UK Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PHP94 Effectiveness and Cost-Benefit of a Bupivacaine Physician Educational Programme in Minimizing the Spinal Anesthesia Failure Rate- Report from a Tertiary-Care Hospital in Central Taiwan

    Nov 1, 2012, 00:00

  • PMS78 Demographİc and Socİoeconomİc Characterİstİcs That Affect Selectİon of İntravenous Versus Subcutaneous İnjectİon Tumor Necrosis Factor Inhİbitors for Rheumatoid Arthritis Patients

    Nov 1, 2012, 00:00

  • PDB35 Validation of the Problem Areas in Diabetes Questionnaire Among Patients With Type 2 Diabetes Mellitus in Singapore- a Pilot Study

    Nov 1, 2012, 00:00

  • PHP22 Pharmacovigilance in Qatar – a Pharmacist Survey

    Nov 1, 2012, 00:00

  • PIN1 Effect of Antitubercolosis Treatment on Lever Enzymes

    Nov 1, 2012, 00:00

  • PRM171 Optimal Shopping- An Evauation of Decision Rules in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PSS11 Economic Evaluation of Biologic Treatments for Moderate to Severe Psoriasis in Italy

    Nov 1, 2012, 00:00

  • PIN88 Cost Implications of Different Practices in Vaccine Provision

    Nov 1, 2012, 00:00

  • PCV98 Health Related Quality of Life and Age in Hypertensive Patients- Self-Perception and Evaluation by Professionals. The Equality Study

    Nov 1, 2012, 00:00

  • PCN27 Analysis of Prevalence and Treatment of Multiple Myeloma in German Statutory Sick Funds Claim Data

    Nov 1, 2012, 00:00

  • PIH33 Utility and Human Capital Loss in Asthma, Chronic Obstructive Pulmonary Disease and Rheumatoid Arthritis – The Impact of Prevalence, Disease Specific Mortality and Utility Decrement on Overall Health Burden

    Nov 1, 2012, 00:00

  • PGI5 Increasing Demands for Medical and Drug Utilization in Patients With Long-Term Irritable Bowel Syndrome in Taiwan

    Nov 1, 2012, 00:00

  • PIN20 Budget Impact of Backbone Choice in Italian Treatment- Naïve, HIV-Infected Patients

    Nov 1, 2012, 00:00

  • PGI9 Analysis of Adherence With Oral 5-Aminosalicylic Acid (5-ASA) Therapy in Patients with Ulcerative Colitis (UC) in a Uk Pharmacy Database

    Nov 1, 2012, 00:00

  • PIH39 Occupational Stress and Burnout- Impact on the Attitudes of Pharmacists in Providing Pharmaceutical Services

    Nov 1, 2012, 00:00

  • PCV122 Hypertension and Disability-Free Life Expectancy From a Cohort Study in Japan –Results From a Nationwide Cohort Study (NIPPON DATA80/90)

    Nov 1, 2012, 00:00

  • PRM14 Proposed Checking Points to Evaluate Report of Multiple Treatment Comparison (MTC) Analysis in the Submission of New Drug Reimbursement and Pricing Application to the National Health Insurance in Taiwan

    Nov 1, 2012, 00:00

  • PMD27 Budget Impact of Selecting Cardiac Resynchronization Therapy (CRT) Devices With Adaptive (“ACRT”) Programming Algorithms Under the United States Medicare Payment Setting

    Nov 1, 2012, 00:00

  • PHP201 Can Risk Management Plans (RMP) Contribute to Health Technology Assessment (HTA) and Knowledge of Safety in Everyday Medical Practice?

    Nov 1, 2012, 00:00

  • PSU14 Economic Impact of Scoliosis in Canada- A RAMQ Database Analysis

    Nov 1, 2012, 00:00

  • PCV35 Costs of Treating Cardiovascular Diseases in Germany- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMD79 A Population-Based Study on the Use of Blood Glucose Monitoring Test Strips

    Nov 1, 2012, 00:00

  • PIN74 Cost Savings Due to Antibiotic Prescription Related to Quick C-Reactive Protein Testing

    Nov 1, 2012, 00:00

  • EX3 A Evaluation of the Effects from China Drug Policy Reform During 2009-2011- Some Success, Many Unintended Effects

    Nov 1, 2012, 00:00

  • PND70 Patient Characteristics and Treatment Status in Parkinson'S Disease (PD)

    Nov 1, 2012, 00:00

  • CA4 A Comparison of Patient and General-Population Utility Values for Advanced Melanoma in Health Economic Modelling

    Nov 1, 2012, 00:00

  • PMH3 Caregiver Perceptions on the Burden of Caring for Dementia Patients- Results from a Cross-Sectional Hospital-Based Study in China

    Nov 1, 2012, 00:00

  • PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • CV4 Evaluation of Telemonitoring for Heart Failure Patients With Implantable Defibrillators- The Evolvo (Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators) Study

    Nov 1, 2012, 00:00

  • PHP144 Economic Effect of Clinical Trials for Turkey

    Nov 1, 2012, 00:00

  • PCV32 The Cost of Diabetes Complications in Belgium

    Nov 1, 2012, 00:00

  • PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy

    Nov 1, 2012, 00:00

  • PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011

    Nov 1, 2012, 00:00

  • PUK6 The Economic Burden of Post-Transplant Events in Renal Transplant Patients in Germany (The Portrait Study)

    Nov 1, 2012, 00:00

  • PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece

    Nov 1, 2012, 00:00

  • PRM131 How Might Experience-Based Utility Measures Influence Reimbursement Decisions?

    Nov 1, 2012, 00:00

  • PDB28 Economic Evaluation of Vildagliptin As Add-on Therapy to Metformin in Diabetes Mellitus Treatment in China

    Nov 1, 2012, 00:00

  • PRS37 Quality of Life in Paediatric Asthma From Patient and Their Parents Perspective

    Nov 1, 2012, 00:00

  • PHS2 Population Risk Stratification- Based on the Cost of Care in Patients With Chronic Diseases

    Nov 1, 2012, 00:00

  • PCN104 Profile of Patients and Health Care Costs Associated With Cancer Treatment From a Medical Cooperative in the State of São Paulo, Brazil

    Nov 1, 2012, 00:00

  • PMD83 The Cost Impact of Modifying Patterns of Self-Monitoring of Blood Glucose in an Irish Type 2 Diabetes Cohort

    Nov 1, 2012, 00:00

  • PCV29 Health Care Resource Utilization and Costs of Cardioembolic Stroke in the Region of Madrid, Spain- Preliminary Results of CODICE Study

    Nov 1, 2012, 00:00

  • PSY16 Cost Utility Analysis of Reduced Intensity Hematopoietic Stem Cell Transplantation in Adolescence and Young Adult With Severe Thalassemia Compared to Hypertransfusion and Iron Chelation Program

    Nov 1, 2012, 00:00

  • PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations

    Nov 1, 2012, 00:00

  • PND60 Non-Diabetic Peripheral Neuropathic Pain is Underdiagnosed in GP Practices Although it has High Impact on Patients' Health Related Quality of Life

    Nov 1, 2012, 00:00

  • PHS23 Direct Medical Costs Associated With Stroke in Non-Valvular Atrial Fibrillation in India

    Nov 1, 2012, 00:00

  • PHS22 Burden of Invasive Pneumococcal Diseases in Older Adults in the New EU Countries of the Central Europe

    Nov 1, 2012, 00:00

  • PIN44 Cost-Effectiveness of Posaconazole Compared to Fluconazole/Itraconazole for the Prevention of Invasive Fungal Infections in Neutropenic Patients

    Nov 1, 2012, 00:00

  • PMD44 Evaluating Strategies for Using DNA Testing to Identify Mucinous Pancreatic Cysts

    Nov 1, 2012, 00:00

  • PCV31 Cost of Cardiovascular Diseases in Serbia

    Nov 1, 2012, 00:00

  • PUK17 Cost-Mimimization Analysis of Pazopanib Versus Sunitinib, Sorafenib and Bevacizumab+ Interferon á-2a for Patients With Metastatic Renal Cell Carcinoma

    Nov 1, 2012, 00:00

  • PRM149 A Random Utlity Model Using a Transaction Cost Politics Approach to Adjust Health Systems to Economic Transition

    Nov 1, 2012, 00:00

  • PIH18 Clinical Efficacy and Cost-Effectiveness of Additional Immunotherapy in Early-Onset Neonatal Infections

    Nov 1, 2012, 00:00

  • PHP164 Payer Information Requirements for Relative Effectiveness Assessment Vary Across Markets and Create Discrepencies in Patient Access to Medicines

    Nov 1, 2012, 00:00

  • PRM6 The UK Contribution to Real World Research- Review of Published Data at ISPOR, Madrid 2011

    Nov 1, 2012, 00:00

  • PHP142 Drug Shortages Around the World and the Underlying Reasons

    Nov 1, 2012, 00:00

  • PRS18 Systematic Review of Economic Evaluations, Utility Estimates, Resource Utilisation, and Costs in Chronic Idiopathic Urticaria

    Nov 1, 2012, 00:00

  • PCV57 Cost-Effectiveness of Ivabradine in Thai Heart Failure Patient

    Nov 1, 2012, 00:00

  • PHP109 Practice Change in Italian Community Pharmacy- An Analysis of Managerial Implication

    Nov 1, 2012, 00:00

  • PCN150 Comparisons of QALYs Gained, Cost Per QALY Gained and ASMRs for 38 Anticancer Drugs in France and the UK- Vive La Difference?

    Nov 1, 2012, 00:00

  • PHS10 HbA1c Testing Frequency in Primary Care Diabetes Patients in Germany and in the UK

    Nov 1, 2012, 00:00

  • PHS88 Pharmacist House Calls in Home Care in Japan

    Nov 1, 2012, 00:00

  • PMD91 Scenario Analysis and Real Options Modeling of Home Brain Monitoring in Epilepsy Patients

    Nov 1, 2012, 00:00

  • PHP64 Evaluation of Public Perception Towards Medicine Quality and Prices in Afghanistan

    Nov 1, 2012, 00:00

  • PIH6 Unintentional Exposures to Buprenorphine/Naloxone Tablets and Oral Film among Children Less Than Six Years Old

    Nov 1, 2012, 00:00

  • PND6 Combining RCT and Observational Data in a Mixed Treatment Comparison of Disease-Modifying-Therapies for Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PHP67 Review of the Currently Listed Drugs in South Korea

    Nov 1, 2012, 00:00

  • PSY45 Social Economic Burden and Health-Related Quality of Life in Patients With Rare Diseases in Europe (BURQOL-RD Project). Spanish Results

    Nov 1, 2012, 00:00

  • PCV110 Multivariate Analysis of Clinical and Patient-Level Factors Associated With Colesevelam Treatment Persistence

    Nov 1, 2012, 00:00

  • PSY24 Economic Evaluation of Opioid Substitution Treatment (OST) in Greece

    Nov 1, 2012, 00:00

  • PHP111 Factors Predicting Reimbursement Decisions on Orphan Drugs in Eight Countries

    Nov 1, 2012, 00:00

  • PHP115 The Sharp Decrease of Drug's Access to Reimbursement in France in 2011

    Nov 1, 2012, 00:00

  • PCN53 Real World Management and Costs in Metastatic Malignant Melanoma (MM) Patients- A Pilot Study Based on an Institutional Patient Registry

    Nov 1, 2012, 00:00

  • PCV73 Prevention of Stroke in Patients With Atrial Fibrillation- Cost-Utility Analysis of Rivaroxaban Versus Warfarin in Slovakia

    Nov 1, 2012, 00:00

  • PHS31 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Musculoskeletal and Connective Tissue Diseases

    Nov 1, 2012, 00:00

  • PCN21 Comparative Effectiveness and Cost-Effectiveness Assessment of Erlotinib Versus Gefitinib in First-Line Treatment of EGFR Activating Mutation Positive Non-Small Cell Lung Cancer for Hong Kong

    Nov 1, 2012, 00:00

  • PUK3 Evaluation of Medication-Related Problems in Hemodialysis Patients

    Nov 1, 2012, 00:00

  • PRM120 Pathways to Effective Clinro Dossier Development

    Nov 1, 2012, 00:00

  • PCV106 Affordability of Anti-Hypertensive Medication in Egypt Under Current Reimbursement Systems

    Nov 1, 2012, 00:00

  • PDB22 Potential Budget Impact of Linagliptin in France Estimated From Current Pattern of Dipeptidyl Peptidase 4 Inhibitors Prescriptions

    Nov 1, 2012, 00:00

  • PHP32 Understanding Accessibility for New Medicines Entering the Market Since 2007 in Portugal Using Survival Analysis

    Nov 1, 2012, 00:00

  • PCV17 A Cross-Sectional Assessment of Atrial Fibrillation Management Among French Patients in Primary Care

    Nov 1, 2012, 00:00

  • RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion- Results from Interviews Conducted As Part of a Time-and-Motion Study (TM) Across 17 Sites

    Nov 1, 2012, 00:00

  • PCN78 Cost-Effectiveness of Plerixafor Plus GCSF for Mobilization of Peripheral Blood Stem Cells in Patients With Myeloma and Lymphoma in Spain

    Nov 1, 2012, 00:00

  • PHP41 Use of Special Payments to Encourage the Adoption of Innovative Medical Technologies in the English NHS

    Nov 1, 2012, 00:00

  • PCN39 Potential Time and Cost Savings with Herceptin (Trastuzumab) Subcutaneous (SC) Injection Versus Herceptin Intravenous (IV) Infusion- Results from Three Different English Patient Settings

    Nov 1, 2012, 00:00

  • PA1 Assessing the Progression of the UK NHS Health Care Reforms and the Impact on Health Care Delivery

    Nov 1, 2012, 00:00

  • PRM161 A Paradigm Shift in Health Economic Evaluations for Developing Countries - Optimization Modelling for Assessing Which Mix of Malaria Prevention Strategies Achieves a Defined Public Health Target at the Lowest Budget

    Nov 1, 2012, 00:00

  • PCN57 Economic Burden of Prostate Cancer in Russia

    Nov 1, 2012, 00:00

  • PHP71 Cost Effectiveness Analysis of Facility and Community Based Provision of Family Planning in Kampala

    Nov 1, 2012, 00:00

  • PIH30 Potentially Inappropriate Prescribing and Adverse Health Outcomes in Community Dwelling Older Populations

    Nov 1, 2012, 00:00

  • PHS15 Recommendation for Rotavirus Vaccination and Herd Effect- Analyzing Cost Data from a German Statutory Health Insurance

    Nov 1, 2012, 00:00

  • PRS1 Cost-Utility of Molecular IgE in Vitro Diagnostics (IVD) in Children Suspected With Peanut Allergy Compared to Most Used Diagnostics in Selected Asian Markets

    Nov 1, 2012, 00:00

  • PA3 Limited Access to Cataract Surgery in Poland

    Nov 1, 2012, 00:00

  • PRM56 Development of a Conceptual Model for Use in Economic Modelling of Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2012, 00:00

  • PMS64 Comparative Efficacy of Tocilizumab and aTNF Biologic Monotherapies on Patient Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDs (DMARD-IR)- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PGI11 Association Between Knowledge and Health Related Quality of Life in Hepatitis B Patients

    Nov 1, 2012, 00:00

  • PCN14 Acute Myeloid Leukaemia Treatment Pathways - a Detailed Costing Study Example

    Nov 1, 2012, 00:00

  • PMH8 A Review of Consequences of Relapse in Schizophrenia

    Nov 1, 2012, 00:00

  • PIN52 Pharmacoeconomical Aspects of Treating Acute Bronchitis Among Adults

    Nov 1, 2012, 00:00

  • PRM58 Long-Term Validation of the IMS CORE Diabetes Model in Type 1 and Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PHP92 The Impact of the Surveillance in Pharmacotherapy by Hospital Health Care Risks Management (HHRM)

    Nov 1, 2012, 00:00

  • PHP136 Generic Price Linkage As a Policy Choi Review of Recent Developments

    Nov 1, 2012, 00:00

  • PHP50 Integrated Closed Intravenous Catheter System Reduces the Occurrence of the Catheter Replacement and the Cost

    Nov 1, 2012, 00:00

  • PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting

    Nov 1, 2012, 00:00

  • PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients

    Nov 1, 2012, 00:00

  • PRM22 Testing the Equivalence of the Label Wording for EQ-5D-5L Response Options Across Different Languages in Singapore

    Nov 1, 2012, 00:00

  • PRM24 Economic Valuation of Informal Care – Task Based Approach

    Nov 1, 2012, 00:00

  • PHP160 Benefits of Probabalistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • MA3 Paliperidone Palmitate Long-Acting Injection for Brazilian Non-Adherent Schizophrenic Patients- 5-Year Budget Impact Analysis From the Public Payer Perspective

    Nov 1, 2012, 00:00

  • PDB12 Role of Chromium in Type-2 Diabetes Therapy- A Systematic Review Study

    Nov 1, 2012, 00:00

  • PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov Model

    Nov 1, 2012, 00:00

  • PMD70 A Five-Year Markov Model Evaluating the Cost-Utility of NASHA/Dx for the Treatment of Fecal Incontinen A United States Perspective

    Nov 1, 2012, 00:00

  • PIH41 Long-Term Fiscal Implications of Funding Assissted Reproductive Therapies- Review of the Literature

    Nov 1, 2012, 00:00

  • PCN130 Role of the Health Care Payment System on the Patient Access to Oral Anticancer Drugs- A Comparison of French and North American Situations

    Nov 1, 2012, 00:00

  • PUK1 Diuretic Activity of Aqueous Extract of Boswellia Serrata Roxb. Oleo Gum in Normal Albino Rats

    Nov 1, 2012, 00:00

  • PHP172 Challenges in Developing a New System for Registration of Patient Registries

    Nov 1, 2012, 00:00

  • PCN147 A Cross European Comparison of Eribulin Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PHP199 The Impact of the German Pharmaceutical Market Reorganisation Act (AMNOG) on the German Reference Price Market – Trends Two Years After the Introduction of the AMNOG

    Nov 1, 2012, 00:00

  • HC4 Tapping Into the Asian Pharmaceutical Market- Global Firms Go Local?

    Nov 1, 2012, 00:00

  • PRM90 Outcome Differences in Algorithms Used for Indirect Mapping of Utility Values From HAQ-DI- An Assessment Based on Phase 2A Clinical Trial Data in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-II-20 MAB)

    Nov 1, 2012, 00:00

  • PUK7 Cost of Illness of Overactive Bladder Syndrome in Hungary

    Nov 1, 2012, 00:00

  • PND25 Burden of Spina Bifida (SB) in Germany - the Characteristics of SB Population

    Nov 1, 2012, 00:00

  • PND52 Validation of Spanish Version of the Huntington Clinical Self-Reported Instrument (H-CSRI)

    Nov 1, 2012, 00:00

  • PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PDB58 The Psychometric Performance of the EQ-5D, SF-6D and Diabetes Health Profile (DHP-18) in Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PRM5 Systematic Review of Cost-Utility Analyses in Asia

    Nov 1, 2012, 00:00

  • PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in Finland

    Nov 1, 2012, 00:00

  • PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating Mutations

    Nov 1, 2012, 00:00

  • PIN55 How Should We Target Cost-Efficacy in the Treatment of HIV-1 Naïve Patients With Recommended Therapies Based on NNRTIS in Spain?

    Nov 1, 2012, 00:00

  • PHS78 Impact of Educational Intervention on Case Management of ARI at Community Pharmacies in Islamabad Pakistan

    Nov 1, 2012, 00:00

  • PRM98 Optimizing Discrete Choice Experiment Designs Using Simulations

    Nov 1, 2012, 00:00

  • PHP78 Similar HTA, Different Access Outcome? Comparison of Orphan Oncology Drug Assessment in South Korea, Australia and the UK

    Nov 1, 2012, 00:00

  • PMS17 The Societal Cost for RA Before and After the Introduction of Biological Drugs- a Swedish National Register Study for 1990-2010

    Nov 1, 2012, 00:00

  • PHP107 Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC Bridge Study- An Interim Analysis of HCC Burden of Illness in the Asia-Pacific (AP) Cohort

    Nov 1, 2012, 00:00

  • PMS45 Exercise Therapy, Manual Therapy, or Both, for Management of Osteoarthritis of the Hip or Knee- Economic Evaluation Alongside a Randomized Clinical Trial

    Nov 1, 2012, 00:00

  • PHP203 How to Optimise Chances for Successful AMNOG Assessments – Best Practice Approach for German Market Access

    Nov 1, 2012, 00:00

  • PDB12 How Hypoglycaemic Events Can Influence Diabetic Patients' Weight and Affect Hba1C Control

    Nov 1, 2012, 00:00

  • PRS8 The Effect of Asthma on Health Status, Work Productivity, and Health Care Resource Use in Urban China

    Nov 1, 2012, 00:00

  • PUK16 Cost-Effectiveness of Ketosteril Treatment in Stage 3-4 CKD Patients

    Nov 1, 2012, 00:00

  • PCN148 Review of National Institute for Health and Clinical Excellence (NICE) Recommendations for Anti-Cancer Agents Across Multiple Drug-Indication Combinations

    Nov 1, 2012, 00:00

  • PUK9 Direct and Indirect Cost of Urge Urinary Incontinence With and Without Pharmacotherapy

    Nov 1, 2012, 00:00

  • PHP163 Assessing the Quality of Manufacturers' Searches in NICE Single Technology Appraisals by Evidence Review Groups

    Nov 1, 2012, 00:00

  • PRM122 Atopic Dermatitis on Families- Creation of a Specific Burden Questionnaire

    Nov 1, 2012, 00:00

  • PCV12 Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations- Network Meta-Analyses

    Nov 1, 2012, 00:00

  • PRM30 Hospitalization Registry and Costs of Benign Prostatic Hyperplasia Patients (BPH) Based on a Public Database (DATASUS) in Brazil

    Nov 1, 2012, 00:00

  • PND31 Economic Value of Slowing Parkinson's Disease in Germany- Modeling Progression Through Hoehn and Yahr Stages

    Nov 1, 2012, 00:00

  • PCV6 Comparison Rivaroxaban with Other Antithrombotic Agents- Effectiveness and Safety of Prophylactic Antithrombotic Agents After Major Orthopedic Surgeries in Taiwan

    Nov 1, 2012, 00:00

  • PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment

    Nov 1, 2012, 00:00

  • PRM39 Evaluation of Patient Centered Outcomes Using Individual Data From a Quality Registry and Patient Reported Abilities and Ratings of Quality in Health Care, in Diabetes Patients in Sweden

    Nov 1, 2012, 00:00

  • PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PRM68 Comparative Computation Speed of Excel, Visual Basic for Applications, R, and Java in Execution of a Microsimulation Model With Probabilistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis

    Nov 1, 2012, 00:00

  • PSU17 The Cost of Surgical Procedure to Remove Adhesions Abdomen or Pelvis in the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PDB15 A1C Variability is Associated With the Risk of Developing New Diabetes for the Healthy Adults

    Nov 1, 2012, 00:00

  • PRM17 Economic Evaluation of Vaccines- Considerations on Evidence, Discounting, Models and Futures Challenges

    Nov 1, 2012, 00:00

  • PHS74 Does Disease Advocacy Impact Priority Setting- Evidence From the Needs and Priorities for Comprehensive Liver Cancer Control in 12 Countries in Europe and Asia-Pacific

    Nov 1, 2012, 00:00

  • PHP82 The Characteristics of Clinical Trials in Asia

    Nov 1, 2012, 00:00

  • PDB64 The Avoidance of Weight Gain is Important for Oral Type 2 Diabetes Treatments in Sweden and Germany- A Patient Preference Study

    Nov 1, 2012, 00:00

  • PCV43 Fair Cost-Benefit Evaluation of Health Care- A Case Study of Blood Pressure Lowering Drugs in France

    Nov 1, 2012, 00:00

  • PDB44 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Mexico

    Nov 1, 2012, 00:00

  • PIH4 Network Meta-Analysis of Pharmacological Interventions to Prevent Venous Thromboembolism Following Elective Knee and Hip Replacement Surgery- Why Extend the Network?

    Nov 1, 2012, 00:00

  • PHS32 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Trauma Patients

    Nov 1, 2012, 00:00

  • PCV1 Evaluation of Statin-Associated Adverse Events- Analysis of the Incidence and Influence of the Concomitant Use of Potential Interacting Drugs

    Nov 1, 2012, 00:00

  • PHP57 Emerging Drug Reimbursement Models- Lessons and Implications from Cancer Drug Access Schemes

    Nov 1, 2012, 00:00

  • PHP182 Concordance of PRO Labeling Claims Between the FDA and EMA

    Nov 1, 2012, 00:00

  • PMS40 Cost-Effectiveness of Denosumab for the Treatment of Male Osteoporosis (MOP) in the Elderly in Sweden

    Nov 1, 2012, 00:00

  • PHP14 2010-2012 Global Health Care Reforms and Their Impact on Pricing, Access and Health Outcomes Strategy

    Nov 1, 2012, 00:00

  • PHP50 Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

    Nov 1, 2012, 00:00

  • PHP99 Implementation of a Formulary Management Programme in Singapore

    Nov 1, 2012, 00:00

  • PHP44 Public Financing of Medicines in Portugal (2007-2011)- Accessibility to Medicinal Products with New Molecules or New Therapeutic Indications

    Nov 1, 2012, 00:00

  • PCV68 Economic Evaluation of Initiation With Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension in Spain

    Nov 1, 2012, 00:00

  • PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab- A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone

    Nov 1, 2012, 00:00

  • PMD69 Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation in the UK

    Nov 1, 2012, 00:00

  • PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in Japan

    Nov 1, 2012, 00:00

  • PHS17 Costs of Influenza A(H1N1)2009 Infection During the Pandemic and the Postpandemic-Seasonal Waves

    Nov 1, 2012, 00:00

  • PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) Countries

    Nov 1, 2012, 00:00

  • PMS52 Drug Use Profile in a Rheumatoid Arthritis Patient Cohort- A Brazilian Health Management Organization Experience

    Nov 1, 2012, 00:00

  • MA2 Observation of Persistence Rates and Potential Cost Savings Associated With Certolizumab Pegol Treatment for Rheumatoid Arthritis in England, Wales and Northern Ireland Clinical Practice

    Nov 1, 2012, 00:00

  • PSU18 Assessment of the Resource Use and Costs Associated With Parathyroidectomy Surgery for Secondary Hyperparathyroidism in End Stage Renal Disease in the UK

    Nov 1, 2012, 00:00

  • PDB8 Weight Loss of ≥3% of Body Weight After Initiating New Anti-Diabetic Therapy is Associated With Glycemic Control at 6 Months in Patients With Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PIH48 Service Uses and Costs of Child and Adolescent Psychiatric Patients Treated with Antipsychotics in Taiwan

    Nov 1, 2012, 00:00

  • PIN12 Burden of Disease and Serotype Distribution Associated With Reportable Invasive Streptococcus Pneumoniae Pneumonia in Norway, 2007–2009

    Nov 1, 2012, 00:00

  • PHP113 Utilization of FPG, HbA1C and Self-Monitoring of Blood Glucose (SMBG) in Community Health Centers in the Shanghai Area

    Nov 1, 2012, 00:00

  • PRM33 Real World Eviden Promise and Pitfalls of Real World Data

    Nov 1, 2012, 00:00

  • PCV34 The Economic Cost of Acute Coronary Syndrome in Turkey

    Nov 1, 2012, 00:00

  • PUK19 Antimuscarinic Persistence Patterns in Newly Treated Patients With Overactive Bladder (OAB)- Retrospective Comparative Analysis of Fesoterodine, Solifenacin and Tolterodine

    Nov 1, 2012, 00:00

  • PSY49 Treatment Patterns in Psoriatic Arthritis (PSA) Patients Newly Initiated on Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

    Nov 1, 2012, 00:00

  • PRM109 Content Validity of a Treatment Satisfaction Questionnaire in Non-Hodgkin's Lymphoma

    Nov 1, 2012, 00:00

  • PCN89 Cost Effectiveness of Treatment With New 6-Month Leuprorelin Acetate Formulation in Patients With Advanced Prostate Cancer

    Nov 1, 2012, 00:00

  • CL4 Drug Switching Events Among Users of NSAIDS With or Without Gastro-Protective Drugs As an Early Determinant of Dissatisfaction From Gastrointestinal Adverse Events

    Nov 1, 2012, 00:00

  • PGI29 Cost of Chronic Hepatitis C (HCV) in Poland – Health Care Professionals Survey

    Nov 1, 2012, 00:00

  • PHP61 Excess Weekend Mortality in Hospitals- A Result of Higher Severity of Illness at the Time of Admissions?

    Nov 1, 2012, 00:00

  • PMS50 Indirect Costs of Rheumatoid Arthritis in Serbia Related to Work Absenteeism, Medical Welfare and Rehabilitation Costs

    Nov 1, 2012, 00:00

  • PHP111 Development of National Medicine Brand Substitution Guidelines and Pilot Assessment of Its Adoptability among Community Pharmacist and General Practitioners in the State of Penang, Malaysia

    Nov 1, 2012, 00:00

  • PHP16 Removing the Barrier of Cost to Smoking Cessation Medications Under the Affordable Care Act of 2010

    Nov 1, 2012, 00:00

  • QL3 Simulations of Adaptive Measurement of Change for Health Related Quality of Life Assesments in Chronic Conditions

    Nov 1, 2012, 00:00

  • PUK10 Comparative Cost-Analysis of Six Anticholinergics for the Treatment of Overactive Bladder and Incontinence in Germany

    Nov 1, 2012, 00:00

  • PIN40 Cost-Effectiveness of Boceprevir-Based Treatment of Chronic Genotype 1 Hepatitis C Virus (HCV) Infection From the Perspective of the German Statutory Health Insurance (SHI)

    Nov 1, 2012, 00:00

  • PMS23 Health Related Quality of Life, Measured by the Short Form-36, of Patients with Rheumatoid Arthritis and Ankylosing Spondylitis in an Urban Population of China

    Nov 1, 2012, 00:00

  • PCN64 Cost-Consequence Analysis (CCA) of the Treatment of Growing Subependymal Giant Cell Astrocytoma (SEGA) Secondary to Tuberous Sclerosis Complex (TSC) in Brazil

    Nov 1, 2012, 00:00

  • DU1 A Time Series Analysis of the Effect of the Co-Payment on Pharmaceutical Consumption in Two Italian Regions

    Nov 1, 2012, 00:00

  • PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal

    Nov 1, 2012, 00:00

  • Editorial Board

    Nov 1, 2012, 00:00

  • PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in Shenyang

    Nov 1, 2012, 00:00

  • CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in Oncology

    Nov 1, 2012, 00:00

  • PMS8 The Mortality and Costs from Hip, Vertebral, Wrist and Other Fractures Among Postmenopausal Women in Taiwan

    Nov 1, 2012, 00:00

  • PDB59 Content Validity of a New Patient-Reported Outcome Instrument to Assess Hypoglycemia- The Hypoglycemia Perspectives Questionnaire

    Nov 1, 2012, 00:00

  • PRM27 Evaluating European Data Sources for Assessing Real-World Effectiveness of New Anti-Diabetic Drugs

    Nov 1, 2012, 00:00

  • PIN43 The Use of Futility Rules in Economic Evaluations With Direct Acting Agents (DAA) in the Treatment of Genotype 1 Hepatitis C Virus (HCV) From a Spanish Health Care Perspective

    Nov 1, 2012, 00:00

  • PMS21 Functional Impairment, Disease Activity, and Duration of Disease Independently Affect the Quality of Life in Patients with Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PCV76 Standard Costs and Resources Allocation in Attainment of Target Lipid Levels among Experienced Statin Users- Results From the STAR Study (Statins Target Assessment in Real Practice)

    Nov 1, 2012, 00:00

  • PUK24 Pharmacoeconomic Aspects of Use of Erythropoietin Drugs in Patients on Hemodialysis in Ukraine

    Nov 1, 2012, 00:00

  • PRM169 Internal and External Validity in Economic Modeling- Considerations Based on a Published Example

    Nov 1, 2012, 00:00

  • PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc)- Analysis of Prescription Claims From the Ramq Database

    Nov 1, 2012, 00:00

  • PRS29 Queuing Statistical Model - A New Tool for Preliminary Cost-Effectiveness Assessments

    Nov 1, 2012, 00:00

  • PGI5 Effectiveness and Safety of Antacids in Pregnant Women Suffering From Gerd/Hyperacidity Symptoms

    Nov 1, 2012, 00:00

  • PCV52 Cost-Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Portugal

    Nov 1, 2012, 00:00

  • PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C- Submission to the National Institute for Health and Clinical Excellence (NICE)

    Nov 1, 2012, 00:00

  • PMD28 Comparing the Cost and Diagnostic Efficiency of Gadoxetic Acid-Enhanced MRI Versus Extracellular Contrast Media-Enhanced MRI and Multidetector Computed Tomography in Patients With Suspected Hepatocellular Carcinoma in Thailand and Kor ...

    Nov 1, 2012, 00:00

  • PDB62 Type 2 Diabetes in Russia- Prevalence, Risk Factors, and Burden

    Nov 1, 2012, 00:00

  • PCV90 A Novel Conceptual Model of Caregiver Burden in Chronic Heart Failure- A Qualitative Study

    Nov 1, 2012, 00:00

  • PCN31 A Cross-Sectional Assessment of the Quality of Life of Cancer Patients and Their Complementary and Alternative Medicines (CAM) Use

    Nov 1, 2012, 00:00

  • PRS32 Allergy Patients Treated With Immunotherapy Experience Increased Quality of Life and Fewer Sick Days After One Year

    Nov 1, 2012, 00:00

  • PCN5 Impact of Erythropoiesis Stimulating Agents on Survival among Patinets With Colorectal Cancer Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • CV2 Age, Dementia, and Evidence-Based Medication Use After Admission for Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PMS58 Frequency of Administration of Biologics has an Impact on Treatment Decision Making

    Nov 1, 2012, 00:00

  • PMS9 Budget Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in a Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PHP78 System-Wide Impact of Payment Schemes for Integrated Care of Chronic Diseases in Europe- Evidence from an Empirical Analysis

    Nov 1, 2012, 00:00

  • PCV116 Impact of the Type of Drug Insurance on Cost of Statins and Anti-Depressants

    Nov 1, 2012, 00:00

  • PMD49 Cost-Effectiveness of the TLC-NOSF Dressing in Venous Leg Ulcers

    Nov 1, 2012, 00:00

  • PCN9 Epidemiology of Venous Thromboembolism Among Cancer Patients in Taiwan

    Nov 1, 2012, 00:00

  • PSS31 Prevalence of Chronic Wounds in Germany — a Secondary Data Analysis

    Nov 1, 2012, 00:00

  • PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey

    Nov 1, 2012, 00:00

  • NI2 The Use of Off-Label Comparators in Nice Appraisals – An Indirect Endorsement?

    Nov 1, 2012, 00:00

  • PSY14 Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukaemia- A Probabilistic Decision Model

    Nov 1, 2012, 00:00

  • PHP146 Pharmacoeconomic Education for Pharmacy Students in the Russian Federation

    Nov 1, 2012, 00:00

  • PCN12 Meta Analytic Comparison of Breast Cancer Risk in Diabetic Women- Important Differences Between Asian and Caucasian Women Suggest Risk Management Startegies

    Nov 1, 2012, 00:00

  • PHP69 Factors May Influence Pattern of Medicine'S Use

    Nov 1, 2012, 00:00

  • PRM60 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for 1st- Line Chronic Myeloid Leukaemia

    Nov 1, 2012, 00:00

  • PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

    Nov 1, 2012, 00:00

  • PSU6 Cost-Effectiveness Analysis of Treatment for Rectal Cancer Following Clinical Complete Response

    Nov 1, 2012, 00:00

  • PRM124 Translation of the Alcohol Timeline Followback (TLFB) in 4 Languages

    Nov 1, 2012, 00:00

  • VA2 Correlates of Protection for Vaccines- When Does a Correlate Equal Protection?

    Nov 1, 2012, 00:00

  • PHP137 Changes in the Medicines Pricing and Reimbursement Approach in Bulgaria

    Nov 1, 2012, 00:00

  • PCN30 Treatment Patterns and Outcomes of Breast Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • UT2 Mapping DLQI on EQ-5D in Psoriasis – Transformation of Skin-Specific Health-Related Quality of Life Into Utilities

    Nov 1, 2012, 00:00

  • PCV91 The Impact of Atrial Fibrilation Symptoms in the Health Related Quality of Life in Spanish Population (Ulises Study)

    Nov 1, 2012, 00:00

  • PCN36 Vinorelbine in Patients With Non-Small Lung Cancer- Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PSY43 Utilization of Pain Medications in Patients With Chronic Lower Back Pain Who Initiated Duloxetine or Standard of Care for the Management of Pain

    Nov 1, 2012, 00:00

  • PCV81 Awareness of Serious Consequences of Non-Compliance and Self-Reported Adherence to Antipaltelet Therapy After Percutaneous Coronary Intervention

    Nov 1, 2012, 00:00

  • PRM71 Differential Time Preference for Money, Life Years and Quality of Life- An Empirical Pilot Study

    Nov 1, 2012, 00:00

  • PCN2 The Relationship of Following Lipid-Lowering Drugs Used With Adjuvant Hormonal Therapy in Breast Cancer Women

    Nov 1, 2012, 00:00

  • PSY4 Studies on Lead Detoxifying Effect of Ascorbic Acid in Traffic Police Subjects of Karachi

    Nov 1, 2012, 00:00

  • PHP13 The Effect of Law for Economical Use of Medications 2006 on the Number of Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PHP24 Assessment of the in Excess NHI-Covered Medications of Outpatients in a 2000-Bed Medical Center in Taiwan

    Nov 1, 2012, 00:00

  • PRM27 Feasibility, Comparability, and Reliability of the Standard Gamble Compared With the Rating Scale and Time Trade-Off Techniques in the EQ-5D-5L Valuation Study

    Nov 1, 2012, 00:00

  • PMH5 Systematic Review and Network Meta-Analysis of Treatments Used for Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PRM133 Reviewing Translatability Prior to Translation and Linguistic Validation of Pros

    Nov 1, 2012, 00:00

  • PGI12 Assessment of Knowledge, Attitude and Practices of Hepatitis B Patients Towards Their Disease

    Nov 1, 2012, 00:00

  • PRM5 Attribution of Benefit to the Three Disease Dimensions Mortality, Morbidity, Quality of Life Within Early Benefit Assessment (EBA) in Germany

    Nov 1, 2012, 00:00

  • PDB1 Real-World Incidence of Hypoglycemia and Associated Costs Among Insulin Glargine-Treated Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PRS40 Are Disease Management Programs for COPD Cost-Saving?

    Nov 1, 2012, 00:00

  • PCN133 Utilisation of Antineoplatic Agents Involved in Treatment of NSCLC in Slovak Republic Within 2008-2011

    Nov 1, 2012, 00:00

  • PDB66 Quantifying the Impact of Poor Glycaemic Control Compared With Guidelines in the Treatment of Type 2 Diabetes in UK Clinical Practice

    Nov 1, 2012, 00:00

  • PRM176 The Value of Further Research- The Added Value of Individual-Level Data

    Nov 1, 2012, 00:00

  • PSS1 Persistence With Statin Therapy and Risk of Psoriasis- A Population-Based Retrospective Cohort Study

    Nov 1, 2012, 00:00

  • PHP14 The Implementation of Essential Medicine Policy in China- Pros and Cons

    Nov 1, 2012, 00:00

  • PDB45 Cost-Effectiveness of Vildagliptin Compared to Generic Sulphonylureas Added on to Metformin From the Portuguese Societal Perspective

    Nov 1, 2012, 00:00

  • PRM85 Internal Validation of the Syreon Diabetes Model

    Nov 1, 2012, 00:00

  • PSS17 Clinical and Economic Analysis of Linezolid for the Treatment of Methicillin Resistant Staphylococcus Aureus Confirmed Complicated Skin and Soft Tissue Infections Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PCV40 Pharmacotherapy Cost of Patients With Hypertension in Bulgaria

    Nov 1, 2012, 00:00

  • PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PCV8 Assessment of 30-Day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention- A Comparative Effectiveness Study of Clopidogrel and Prasugrel

    Nov 1, 2012, 00:00

  • PCV72 Cost-Effectiveness of Rivaroxaban Versus Acenocumarol in the Stroke Prevention in Patients With Non-Valvular Atrial Fibrilation in the Spanish Setting

    Nov 1, 2012, 00:00

  • PND11 Estimating Survival-Benefit of New Therapeutic Interventions in Cystic Fibrosis Patients in Germany, France, UK and Ireland

    Nov 1, 2012, 00:00

  • PRM104 Examination of Patient Preferen Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments

    Nov 1, 2012, 00:00

  • PMD25 Financial Impact of Adaptive Cardiac Resynchronization Therapy (ACRT) Device Algorithms in the United Kigdom, Germany, Australia and Canada- Are There Savings Associated With Device Selection?

    Nov 1, 2012, 00:00

  • PCV7 Implementing and Evaluating Pharmacist-Managed Warfarin Service in Inpatient and Outpatient Setting in Taiwan

    Nov 1, 2012, 00:00

  • PCN103 How Much Price Component is Accounted for in State Drugs Purchase Decisions in Ukrainian Oncology?

    Nov 1, 2012, 00:00

  • PSS23 Patient Burden Associated With Lack of Treatment Satisfaction Amongst Psoriasis Patients Receiving Traditional Systemic Therapies

    Nov 1, 2012, 00:00

  • PRM21 Validity and Reliability of the 8-Item Morisky Medication Adherence Scale in Patients Taking Warfarin in Singapore

    Nov 1, 2012, 00:00

  • PCN75 Survival and Costs in Metastatic Renal Cell Carcinoma- A Comparison of mRCC Treatment Pre- and Post Tyrosine Kinase Inhibitor (TKI) Introduction Using Retrospective Registry Data

    Nov 1, 2012, 00:00

  • PMD78 The Switch Study- The Impact of Continuous Glucose Monitoring on Quality of Life and Treatment Satisfaction

    Nov 1, 2012, 00:00

  • PDB76 Clinical Effectiveness of Increased Physical Activity in Type 2 Diabetes, Systematic Review

    Nov 1, 2012, 00:00

  • PCV104 Relationship Between Comorbidities, Blood Pressure Control and Therapeutic Schemes in Real-Life Setting Hypertensive Patients

    Nov 1, 2012, 00:00

  • PSS32 Predictors of Biologic Treatment in Psoriasis Population

    Nov 1, 2012, 00:00

  • PHP74 Cost-of-Illness of Patient-Reported Adverse Drug Events – a Population-Based Survey

    Nov 1, 2012, 00:00

  • PHP66 Socioeconomic Inequalities in Health in Urban Pakistan

    Nov 1, 2012, 00:00

  • PGI20 Cost-Effectiveness of Adalimumab for Treatment of Crohn's Disease in Germany

    Nov 1, 2012, 00:00

  • PHP100 Prevention or Treatment? Preferences of the Australian Public for Health Technology Assessment Funding Criteria

    Nov 1, 2012, 00:00

  • PHP61 To Evaluate the Effectiveness and Cost of Pharmaceutical Care Volunteer Set Up by Tainan City Government Involved in the Hospital Attached Home Care Patients

    Nov 1, 2012, 00:00

  • PHP33 The Use of Extreme Value Statistics in Assessing Long Decision Times in Public Funding of Medicines with New Molecules or Therapeutic Indications

    Nov 1, 2012, 00:00

  • PRM121 Burden of Osteoarthritis- Development of a Questionnaire

    Nov 1, 2012, 00:00

  • PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • PCV111 Unmet Therapeutic Needs for Patients With Dyslipidemia According to ATP III Guidelines

    Nov 1, 2012, 00:00

  • PSU33 Characteristics and Burden of Tuberous Sclerosis Complex- Results of a Patient and Caregiver Survey in the United States

    Nov 1, 2012, 00:00

  • PIN10 Epidemiology and Economic Burden of Pneumomococcal Disease in Older Adults in Taiwan

    Nov 1, 2012, 00:00

  • PSS3 The Efficacy of Epidermal Growth Factor in Burn Wound Treatment

    Nov 1, 2012, 00:00

  • PMH34 Persistence in Use of Antidepressants in Pregnant Women Enrolled in Medicaid in the United States

    Nov 1, 2012, 00:00

  • PCV22 Pharmacist'S Involvement in a Multidisciplinary Ischemic Stroke Team in and its Associated Cost Avoidance

    Nov 1, 2012, 00:00

  • PCV96 Relationship Between Inflammation and Patient Functioning in Cardiovascular Disease- A Review of the Literature

    Nov 1, 2012, 00:00

  • PHP86 Cost-Effectiveness in Health Care Programs- A Literature Review

    Nov 1, 2012, 00:00

  • PUK12 Cost-Effectiveness of Immunosuppressive Regimens in Renal Transplant Recipients in Germany- A Model Update

    Nov 1, 2012, 00:00

  • PMS23 Total Health Care Costs Associated With Ankylosing Spondylitis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PIN25 Health and Economic Benefits of Avoiding Hospital Pen Moves for Dairy Cattle in the United States

    Nov 1, 2012, 00:00

  • PDB63 Improvements in Health-Related Quality of Life in Acromegaly With Pasireotide LAR and Octreotide LAR- Results From a Large, Randomized, Double-Blind Phase III Trial

    Nov 1, 2012, 00:00

  • RU4 Universal Versus Selective Screening for Down'S Syndrome- An Economic Evaluation of Resource Use and Costs by Screening Policy

    Nov 1, 2012, 00:00

  • PIH14 Cost of Illness in Women with Endometriosis

    Nov 1, 2012, 00:00

  • PHP59 Exploring the Health and Living Standards of Those Who Don't Report Their Migration Status in a Population-Based Survey- The Case of Chile

    Nov 1, 2012, 00:00

  • PCV115 Burden of Hypertension in Selected EU Countries- 2010-2025

    Nov 1, 2012, 00:00

  • PRM16 Access to Cost Data Capture Using Public Database, Website and Literature in Germany, France, Spain and USA

    Nov 1, 2012, 00:00

  • PA2 Hospital-Based HTA in Italy- Diffusion and Potential Impact

    Nov 1, 2012, 00:00

  • PMH17 Economic Burden in Schizophrenia- A Literature Review

    Nov 1, 2012, 00:00

  • PCN58 Health Economic Impact of Colorectal Cancer

    Nov 1, 2012, 00:00

  • PSY17 Cost-Utility Analysis of Immune Tolerance Induction (ITI) Therapy Versus On-Demand Treatment With Recombinant FVII (rFVIIa) for Hemophilia A With High Titer Inhibitors in Iran

    Nov 1, 2012, 00:00

  • PDB79 Treatment Patterns of Oral Anti-Diabetic Drugs in the UK

    Nov 1, 2012, 00:00

  • PMH51 Real World Add-on and Switch Patterns for Different Formulation of Methylphenidate

    Nov 1, 2012, 00:00

  • PHP177 Characteristics of Patients Not Consuming Pharmacological Resources Due to a Lack of Drug Prescription During Their Hospital Admission

    Nov 1, 2012, 00:00

  • PMH22 Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

    Nov 1, 2012, 00:00

  • PCV101 Japanese Patients and Physicians Preferences for Anticoagulants Use in Atrial Fibrillation - Results From a Conjoint-Analysis Study

    Nov 1, 2012, 00:00

  • PRM74 Cost Effectiveness of Tirofiban in Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PCV80 A Retrospective Study of Comparing Compliance and Persistence of Free Combination Antihypertensive Therapy Versus Single-Pill Combination- Korean Case

    Nov 1, 2012, 00:00

  • PHP170 The Swiss Health Technology Assessment (HTA) Consensus- Guiding Principles

    Nov 1, 2012, 00:00

  • PHS59 Demographics and Health-State Utilities of Irish Patients With Hepatitis C Infection; Use of the 5-Level EQ-5D Questionnaire

    Nov 1, 2012, 00:00

  • PCN121 Decitabine Reduces Transfusion Dependence in Older Patients With Acute Myeloid Leukaemia- Results From a Post-Hoc Analysis of a Randomised Phase III Trial

    Nov 1, 2012, 00:00

  • PHP106 Diffusion of Non-Guideline Experience-Based Chemotherapy Care

    Nov 1, 2012, 00:00

  • PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany

    Nov 1, 2012, 00:00

  • PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK- A Cost-Utility Analysis

    Nov 1, 2012, 00:00

  • PCN28 Statin Use and Risk of Breast Cancer- A Meta-Analysis of 24 Observational Studies

    Nov 1, 2012, 00:00

  • PMS18 Importance of COI Studies in the Health Care-Related Decision-Making Process Through the Example of Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PRM128 Development of a Translation Evidence Tracking Tool to Comply With the FDA Review Requirements for the Translation of PRO Instruments

    Nov 1, 2012, 00:00

  • PIH29 Identification of Factors and Their Influence on Patient Adherence to Intravenous Medication for Chronic Conditions- Findings of a Literature Review in Osteoporosis and Crohn's Disease

    Nov 1, 2012, 00:00

  • PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported Outcomes

    Nov 1, 2012, 00:00

  • PRM138 A Propensity to Get It Right. A Monte Carlo Simulation Study Comparing Statistical Methods to Obtain Correct Cost-Effectiveness Estimates in Observational Studies

    Nov 1, 2012, 00:00

  • PHP131 Ensuring That Phase III Programs are Designed to Meet the Evolving HTA Requirements Across the EU5

    Nov 1, 2012, 00:00

  • PMS25 Structure of Direct Cost of Care of Patients Treated for Severe Rheumatoid Arthritis in France

    Nov 1, 2012, 00:00

  • PMD5 Clinical and Cost-Effectiveness of Third-Generation, Implantable Left Ventricular Assist Devices for People With End-Stage Heart Failure- A Systematic Review

    Nov 1, 2012, 00:00

  • PMS1 Characteristics of Patients With Rheumatoid Arthritis in Turkey- Results from the Turkish League Against Rheumatism RA Registry

    Nov 1, 2012, 00:00

  • PCV20 Possible Budget Impact of Internal Reference Pricing for Statins in Turkey

    Nov 1, 2012, 00:00

  • PND67 The Impact of Memantine and Cholinesterase Inhibitors Initiation for Alzheimer'S Disease on the Use of Antipsychotics Agents- Analysis Using the Ramq Database

    Nov 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126 (current)
  • 127
  • 128
  • 129
  • 130
  • »